The 20 Best Tongue Cancer Doctors Near Me in New York, US

Ian Ganly is a General Surgeon practicing medicine in New York, New York. Dr. Ganly is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Tongue Cancer, Thyroidectomy, and Laryngectomy. Dr. Ganly is currently accepting new patients.

Brian Schmidt is an Oral and Maxillofacial Surgeon practicing medicine in New York, New York. Dr. Schmidt is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Oral Squamous Cell Carcinoma, Breast Cancer, Gastrostomy, and Mastectomy.

Mark Urken is an Otolaryngologist practicing medicine in New York, New York. Dr. Urken is rated as an Elite provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 52 other conditions, according to our data. His clinical expertise encompasses Thyroid Cancer, Tongue Cancer, Throat Cancer, Laryngectomy, and Thyroidectomy. Dr. Urken is currently accepting new patients.

. Dr. Redd is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Infant Hearing Loss, DFNB1, Jones Syndrome, and Meniere Disease.

. Dr. Ferrara is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Mikulicz Disease, Male Pattern Baldness, Salivary Duct Stones, Mouth Ulcers, and Gastrostomy.

. Dr. Korytko is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 41 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Throat Cancer, and Lung Adenocarcinoma.

. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Iron Deficiency Anemia.

. Dr. Allerton is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Familial Prostate Cancer. Dr. Allerton is board certified in American Board Of Internal Medicine, Hematology, American Board Of Internal Medicine, Medical Oncology, American Board Of Internal Medicine, Hospice And Palliative Medicine, and American Board Of Internal Medicine, Internal Medicine.

"Andrew Salama, DDS, MD, is the chief of oral and maxillofacial surgery at Long Island Jewish Medical Center at Northwell. He specializes in head and neck cancer and microvascular reconstruction.Dr. Salama's path toward his specialty actually began in the waiting room of his oral and maxillofacial surgeon, when he was preparing to get his wisdom teeth removed as a college student. Amid the usual magazines were medical journals describing surgeries related to oral and maxillofacial surgery.""I thought it was fascinating, and that led to dental school,"" he recalls. ""On my very first day there, one of the oral and maxillofacial faculty presented a lecture on head and neck cancer, and I remember thinking, 'I want to do that.' It seemed like a dynamic specialty with evidence-based practice, and also one that offered the opportunity to build strong and longitudinal doctor-patient relationships.""After graduating from the University of Maryland Dental School in 1999, Dr. Salama attended the University of Maryland School of Medicine, graduating in 2002. He did his residency in oral and maxillofacial surgery and then completed a two-year fellowship in head and neck oncologic surgery. He remained on faculty for four years before moving to Boston as the director of maxillofacial oncology at Boston University Medical Center. After 11 years in Boston, he joined Northwell in July 2021 with the aim of blending his leadership skills with patient care.""Surgeons only spend about 15 to 20% of their time actually performing surgery, which means it's crucial to find activity that makes the other 80% of time meaningful,"" Dr. Salama explains. ""People simply like working at Northwell; it's a happy place that provides high-quality health care. I came here because it's a supportive environment that is dedicated to positive patient outcomes.""Although Dr. Salama enjoys keeping up with the innovations in his field and drawing on the collaborative environment within Northwell, what he appreciates most in his role are the connections he makes with patients.""There's magic there, when you're working together toward better health,"" he says. ""The relationship and trust between doctors and patients is a large part of what meaningful health care is about. Interacting with patients and their families, and finding solutions to their problems, is what makes me excited to come in every day.""". Dr. Salama is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Ewing Sarcoma, Oral Squamous Cell Carcinoma, Osteotomy, and Glossectomy. Dr. Salama is board certified in American Board Of Oral & Maxillofacial Surgery.

Dr. Bhuvanesh Singh, a board-certified otolaryngologist and physician scientist with a distinction in research, specializes in head and neck surgery and reconstruction with a particular expertise in skin cancers. He joins Northwell after 27 years at Memorial Sloan-Kettering Cancer Center, where he served as the director of Laboratory of Epithelial Cancer Biology and founder and co-director of the Advanced Skin Cancer Management and Prevention Program. A recognized leader in his field, Dr. Singh has served on the AJCC staging and NCCN guideline committees. He has published over 300 peer-reviewed manuscripts, 30 book chapters, and several textbooks, including one of the leading textbooks in head and neck oncology. He has delivered over 500 lectures worldwide. Additionally, as an NIH-funded researcher, he developed a novel antineoplastic compound that is currently being codeveloped with a pharmaceutical company for human use.Dr. Singh has performed over 10,000 surgical procedures, the experience from which has allowed him to develop innovative surgical approaches that have significantly enhanced outcomes for the many common head and neck oncological and reconstructive procedures such as thyroidectomy, neck dissection, and oral cavity and scalp reconstruction. His combined expertise in cancer ablation and facial cosmetic and reconstructive surgery enables him to optimize cancer treatment while achieving excellent cosmetic and functional results for his patients. Dr. Singh values the doctor-patient relationship, treating every patient as he would a family member. He has developed evidence-based strategies to enhance this relationship, emphasizing effective communication and care among all team members. By prioritizing holistic care and collaborative approaches, Dr. Singh aims to ensure that each patient feels valued and supported throughout their treatment journey. Dr. Singh is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Tissue Biopsy, and Thyroidectomy. Dr. Singh is board certified in American Board Of Otolaryngology.

My career began at Beth Israel Medical Center/Continuum Health Partners in Manhattan, as a Physician-Scientist at that institution s newly established Institute for Head and Neck and Thyroid Cancer. I developed a basic science research laboratory, collaborating with senior investigators at the NYU School of Dental Medicine. My research was funded through a combination of national society and private foundation career development awards, and resulted in several publications, nationally recognized basic science research in head and neck oncology, and several national presentations and awards. In 2007, I was hired as Chief of the Division of Head and Neck Surgery at Long Island Jewish Medical Center (LIJ), in the early years of the (then) North Shore-LIJ Health System and North Shore-LIJ Cancer Institute. In this role I helped to establish one of the first fully integrated multidisciplinary oncology programs in our growing health system dedicated to the initial evaluation, care and survivorship of cancer patients, specifically those with head and neck tumors. The Head and Neck Oncology Program at Northwell has now evolved into one of regional as well as national renown, with the ability to deliver sophisticated multidisciplinary surgical and nonsurgical head and neck oncologic care at multiple sites throughout our network. Our clinical team also maintains a close collaboration with leading senior basic science investigators at Northwell's Feinstein Institute, focusing on HPV-associated oropharynx cancer. In 2014, I was appointed Northwell Health Cancer Institute s first Director of Surgical Oncology, and served in this position until early 2019. In the Spring of 2019, I was appointed Director of Operations of the Northwell Health Cancer Institute. In this capacity I serve as the liaison between the Institute, its members, and the various hospitals and outpatient cancer treatment facilities throughout the Northwell network where cancer care is delivered. In 2015, I was appointed Chair of LIJ s Commission on Cancer (CoC) recognized Cancer Committee. In this role I have worked with clinical and administrative colleagues to better integrate the inpatient cancer activities and resources of LIJ and North Shore University Hospital with those of our outpatient Cancer Institute facilities. I am presently involved in defining and solidifying Cancer Institute oversight over inpatient cancer related resources and activities, as well as CoC standards. My clinical leadership and program building accomplishments have been recognized both regionally as well as nationally with an American Cancer Society Doctor of Distinction Award (2017), an American Head and Neck Society Presidential Citation (2017), and a position on the Advanced Training Council of the American Head and Neck Society. Dr. Frank is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Thyroidectomy, and Glossectomy. Dr. Frank is board certified in American Board Of Otolaryngology.

Dev Kamdar is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Kamdar is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Mikulicz Disease, Gastrostomy, and Laryngectomy. Dr. Kamdar is board certified in American Board Of Otolaryngology.

Lucio Pereira is an Otolaryngologist practicing medicine in New Hyde Park, New York. Dr. Pereira is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Oral Squamous Cell Carcinoma, Mikulicz Disease, Tongue Cancer, Gastrostomy, and Laryngectomy. Dr. Pereira is board certified in American Board Of Otolaryngology.

Assistant Professor of Radiation MedicineThe Center for Head & Neck OncologyNorthShore-LIJ-Stereotactic-Radiation-CenterHofstra North Shore- LIJ School of Medicine. Dr. Ghaly is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Adenoid Cystic Carcinoma, Olfactory Neuroblastoma, and Teratocarcinosarcoma.

"Brett Miles, DDS, MD, is vice president of otolaryngology for Northwell facilities in New York City boroughs and Westchester County. He is also the chair of otolaryngology and head and neck surgery at Lenox Hill Hospital and Manhattan Ear, Eye Throat Hospital, and the surgical lead of the head and neck disease management team in the Northwell Health Cancer Institute.Dr. Miles manages head and neck tumors, including those of the mouth and throat, with state-of-the-art surgical techniques including microvascular reconstruction. His clinical interests include computerized reconstruction, minimally invasive robotic surgery and HPV-related head and neck cancer.""Head and neck cancer can be challenging to treat, but highly meaningful,"" Dr. Miles says. ""The relationships I form with my patients are a source of personal motivation. Seeing them move forward with their lives after treatment is inspiring.""Dr. Miles earned a medical degree from University of Texas Southwestern Medical School and a doctorate of dental surgery from Creighton University. He completed residencies in Oral and Maxillofacial surgery and Otolaryngology-Head and Neck surgery at the University of Texas Southwestern Medical Center. He received fellowship training in head and neck oncology at the University of Toronto and is board-certified by both the American Board of Oral and Maxillofacial Surgery and the American Board of Otolaryngology - Head Neck Surgery.Dr. Miles works collaboratively with a team of experts to offer the highest quality cancer care and access to clinical trials. They include imaging specialists, radiation oncologists, medical oncologists, nurse practitioners, and speech and swallowing therapists.Dr. Miles is a Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He has published 170 articles in peer-reviewed journals and often lectures at national and international conferences. He is on the council of the International Association of Oral Oncology, and the American Head and Neck Society's Reconstructive Head and Neck Research Board. He has been a New York Magazine and a New York Metro Area Top Doctor for the last several years.Overall, compassion and empathy are integral to his job. ""Undergoing cancer surgery is a very stressful time for patients and families,"" Dr. Miles says. ""My focus is on cancer and the people affected by cancer.""". Dr. Miles is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 22 other conditions, according to our data. His clinical expertise encompasses Human Papillomavirus Infection, Adenoid Cystic Carcinoma, Salivary Gland Tumors, Laryngectomy, and Gastrostomy. Dr. Miles is board certified in American Board Of Oral & Maxillofacial Surgery and American Board Of Otolaryngology-Head & Neck Surgery.

Duncan Savage is a Radiation Oncologist practicing medicine in Troy, New York. He has been practicing medicine for over 45 years. Dr. Savage is rated as an Experienced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Savage is board certified in American Board Of Radiology Subspecialty, Radiation Oncology. Dr. Savage is currently accepting new patients.

Patrick Morris is an Oncologist practicing medicine in New York, New York. Dr. Morris is rated as a Distinguished provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Tongue Cancer, Breast Cancer, HER-2 Positive Breast Cancer, Tissue Biopsy, and Vertebroplasty.

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Henick is board certified in Internal Medicine. Dr. Henick is currently accepting new patients.

Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. She is also highly rated in 28 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

"David Hirsch, MD, DDS, is the senior vice president of dental medicine at Northwell and chair of oral and maxillofacial surgery at Lenox Hill Hospital. He is also the chair of dental medicine and oral and maxillofacial surgery at Long Island Jewish Medical Center and North Shore University Hospital.Dr. Hirsch performs surgery to treat people with head and neck tumors and specializes in virtual surgical planning-the use of a patient's imaging scans to create 3D models of the anatomy to plan complex head and neck reconstructions involving the skull and jaw. He developed the groundbreaking ""Jaw in a Day"" procedure, which includes removing the tumor, grafting new bone into the jaw, reconstructing the jaw and performing dental restoration all at once, rather than in three separate surgeries.""My dad was a dentist and had an influence on my career goals,"" says Dr. Hirsch, a graduate of the NYU College of Dentistry. Because of a strong interest in head and neck anatomy, and an interest in performing complex surgery, he also decided to pursue a medical degree at NYU Grossman School of Medicine. After a residency in oral and maxillofacial surgery at NYC Health + Hospitals/Bellevue, he completed fellowship training in head and neck surgical oncology at Legacy Emanuel Hospital - Providence Cancer Institute.A team-based approach to care that includes plastic surgeons, maxillofacial prosthodontists-who create prosthetic devices for the jaw-dental specialists, nutritionists and physical therapists is key to ensuring good patient outcomes. Dr. Hirsch encourages his patients to be an active part of the treatment decision-making process. ""Everyone we treat gets personalized care,"" says Dr. Hirsch. ""When a patient calls in the middle of the night, I'm the one who answers the phone.""In addition to his clinical work, Dr. Hirsch is professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is also a member of the American Head and Neck Society, a fellow of the American College of Surgeon, and is board-certified in oral and maxillofacial surgery.One of the most valued parts of his job is the relationships he forms with patients. ""Because I'm involved in lifesaving treatment, I create strong bonds with people,"" says Dr. Hirsch. ""I get to see patients throughout their lives, and they become like family.""". Dr. Hirsch is rated as an Advanced provider by MediFind in the treatment of Tongue Cancer. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Bone Tumor, Oral Squamous Cell Carcinoma, Tongue Cancer, Osteotomy, and Bone Graft. Dr. Hirsch is board certified in American Board Of Oral & Maxillofacial Surgery.